National Health Investors (NYSE:NHI) Hits New 12-Month High at $62.31

National Health Investors, Inc. (NYSE:NHI)’s share price reached a new 52-week high on Thursday . The company traded as high as $62.31 and last traded at $62.02, with a volume of 4189 shares trading hands. The stock had previously closed at $61.82.

Analysts Set New Price Targets

Several equities research analysts have issued reports on the stock. Deutsche Bank Aktiengesellschaft assumed coverage on shares of National Health Investors in a research note on Tuesday, January 30th. They issued a “buy” rating and a $69.00 price target on the stock. StockNews.com upgraded National Health Investors from a “hold” rating to a “buy” rating in a research note on Monday. Wells Fargo & Company upgraded National Health Investors from an “equal weight” rating to an “overweight” rating and upped their price objective for the stock from $55.00 to $63.00 in a research note on Monday, February 26th. BMO Capital Markets upgraded shares of National Health Investors from a “market perform” rating to an “outperform” rating and set a $67.00 target price for the company in a research note on Tuesday, March 12th. Finally, Wedbush lifted their price objective on shares of National Health Investors from $64.00 to $66.00 and gave the stock an “outperform” rating in a research report on Monday, March 18th. Four investment analysts have rated the stock with a hold rating and five have given a buy rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $59.22.

National Health Investors Stock Performance

The firm has a market capitalization of $2.71 billion, a P/E ratio of 19.75 and a beta of 0.94. The company has a 50-day moving average of $56.58 and a 200-day moving average of $54.23. The company has a current ratio of 10.27, a quick ratio of 10.27 and a debt-to-equity ratio of 0.90.

National Health Investors Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, May 3rd. Shareholders of record on Thursday, March 28th will be issued a dividend of $0.90 per share. The ex-dividend date of this dividend is Wednesday, March 27th. This represents a $3.60 annualized dividend and a yield of 5.76%. National Health Investors’s payout ratio is 115.02%.

Insider Transactions at National Health Investors

In other National Health Investors news, Director Charlotte A. Swafford purchased 10,000 shares of the business’s stock in a transaction on Tuesday, February 27th. The shares were purchased at an average cost of $58.69 per share, for a total transaction of $586,900.00. Following the acquisition, the director now owns 110,185 shares of the company’s stock, valued at $6,466,757.65. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. 7.26% of the stock is currently owned by corporate insiders.

Institutional Trading of National Health Investors

Several hedge funds have recently bought and sold shares of the business. PNC Financial Services Group Inc. increased its holdings in National Health Investors by 6.4% during the 4th quarter. PNC Financial Services Group Inc. now owns 3,979 shares of the real estate investment trust’s stock worth $222,000 after purchasing an additional 238 shares in the last quarter. Goldman Sachs Group Inc. raised its position in National Health Investors by 21.5% in the 4th quarter. Goldman Sachs Group Inc. now owns 118,464 shares of the real estate investment trust’s stock valued at $6,616,000 after buying an additional 20,971 shares during the last quarter. Price T Rowe Associates Inc. MD lifted its stake in National Health Investors by 3.7% during the 4th quarter. Price T Rowe Associates Inc. MD now owns 25,320 shares of the real estate investment trust’s stock valued at $1,415,000 after acquiring an additional 910 shares in the last quarter. Legal & General Group Plc boosted its holdings in National Health Investors by 3.6% during the 4th quarter. Legal & General Group Plc now owns 322,917 shares of the real estate investment trust’s stock worth $18,035,000 after acquiring an additional 11,161 shares during the last quarter. Finally, Barclays PLC grew its stake in shares of National Health Investors by 254.0% in the 4th quarter. Barclays PLC now owns 68,940 shares of the real estate investment trust’s stock worth $3,850,000 after acquiring an additional 49,466 shares in the last quarter. Institutional investors and hedge funds own 62.51% of the company’s stock.

About National Health Investors

Incorporated in 1991, National Health Investors, Inc (NYSE:NHI) is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.